Efficacy of newer agents in the glycaemic management of patients with type 2 diabetes

被引：2
|
作者：
Chudleigh, Richard A. [1 ]
Bain, Steve C. [2 ]
机构：
[1] Swansea Bay Univ Hlth Board, Singleton Hosp, Swansea, W Glam, Wales
[2] Swansea Univ, Med Sch, Diabet Res Unit Cymru, Swansea, W Glam, Wales
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2020年 / 36卷 / 02期
关键词：
ONCE-DAILY LIRAGLUTIDE; CARDIOVASCULAR OUTCOMES; OPEN-LABEL; EXENATIDE; METFORMIN; SAFETY; CANAGLIFLOZIN; LIXISENATIDE; SITAGLIPTIN; DULAGLUTIDE;
D O I：
10.1080/03007995.2019.1678344
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [21] Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients
    Ajjan, Ramzi A.
    Abougila, Kamal
    Bellary, Srikanth
    Collier, Andrew
    Franke, Bernd
    Jude, Edward B.
    Rayman, Gerry
    Robinson, Anthony
    Singh, Baldev M.
    DIABETES & VASCULAR DISEASE RESEARCH, 2016, 13 (03): : 211 - 219
  • [22] Factors affecting glycaemic variability in patients with type 2 diabetes
    Yoo, S. -Y.
    Lee, S. -A.
    Chin, H. -J.
    Lee, D. -H.
    Koh, G.
    DIABETOLOGIA, 2014, 57 : S214 - S215
  • [23] The Effects of Depression on Glycaemic Control in Patients with Type 2 Diabetes
    Zhu, Jasmine J.
    Hare, David L.
    Jerums, George
    Stewart, Andrew G.
    Macisaac, Richard J.
    DIABETES, 2014, 63 : A592 - A592
  • [24] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and inadequate glycaemic control on glimepiride monotherapy
    Strojek, K.
    Hruba, A.
    Elze, M.
    Langkilde, A.
    Parikh, S.
    DIABETOLOGIA, 2010, 53
  • [25] Efficacy and safety of standardised glycaemic control in adult and geriatric hospitalised patients with type 2 diabetes mellitus
    Neubauer, K. M.
    Mader, J. K.
    Aberer, F.
    Schaupp, L.
    Donsa, K.
    Augustin, T.
    Beck, P.
    Pieber, T. R.
    Plank, J.
    DIABETOLOGIA, 2015, 58 : S445 - S445
  • [26] Insulin glargine and its role in glycaemic management of Type 2 diabetes
    Elrishi, M. A.
    Jarvis, J.
    Khunti, K.
    Davies, M. J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1099 - 1110
  • [27] Insulin degludec is superior to sitagliptin in improving glycaemic control in uncontrolled patients with type 2 diabetes on oral agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    DIABETOLOGIA, 2012, 55 : S22 - S22
  • [28] THE COMPARATIVE EFFECT OF NEWER ANTIDIABETIC AGENTS ON ENDOTHELIAL FUNCTION AND ARTERIAL WALL PROPERTIES IN PATIENTS WITH TYPE 2 DIABETES
    Bletsa, Evanthia
    Stampouloglou, Panagiota K.
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Gouliopoulos, Nikolaos
    Tsigkou, Vasiliki
    Paschou, Stavroula
    Kassi, Eva
    Tentolouris, Nikolaos, Sr.
    Tsioufis, Konstantinos
    Vavouranakis, Emmanouil
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1523 - 1523
  • [29] Prescriptions of newer glucose regulating agents in older hospitalized patients with type 2 diabetes A retrospective cohort study
    Janssen, Merel L. J. M.
    van der Linden, Carolien M. J.
    Deenen, Maarten J.
    Spies, Petra E.
    Jacobs, Anne
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2023, 12
  • [30] Age differences in efficacy of newer glucose lowering treatments for type 2 diabetes
    Hanlon, P.
    Butterly, E.
    Wei, L.
    Wightman, H.
    Almazam, S. A. M.
    Alsallumi, K.
    Crowther, J.
    Mcchrystal, R.
    Rennison, H.
    Hughes, K.
    Lewsey, J.
    Lindsay, R.
    Mcgurnaghan, S.
    Petrie, J.
    Tomlinson, L. A.
    Wild, S.
    Adler, A.
    Sattar, N.
    Phillippo, D. M.
    Dias, S.
    Welton, N. J.
    Mcallister, D. A.
    AGE AND AGEING, 2025, 54 : I20 - I20
12345